Companies: 10,795·Total market cap: $144.5T
BioAtla, Inc.

BioAtla, Inc.

BCABNASDAQHealthcare● Active
$3.31
$-0.02(-0.60%)
Market Cap$4174023
P/E Ratio
52W High$71.5
52W Low$3.12
Overview

BioAtla, Inc.(BCAB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BCAB · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$2.00M$11.00M$0.00M$0.00M$0.25M
Cost of Revenue$0.00M$0.93M$1.22M$1.20M$0.00M
Gross Profit$2.00M$10.07M($1.22M)($1.20M)$0.25M
Gross Margin %(computed)100.00%91.59%100.00%
Operating Expenses
R&D Expenses$43.57M$63.09M$103.73M$79.35M$58.27M
G&A Expenses$17.73M$21.85M$25.96M$28.79M$38.42M
Total Operating Expenses$61.30M$84.02M$128.47M$106.94M$96.69M
Operating Income($59.30M)($73.94M)($129.69M)($108.14M)($96.44M)
Operating Margin %(computed)-672.21%
Interest Income$0.84M$3.37M$6.31M$1.65M$0.35M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($59.61M)($69.78M)($123.46M)($106.48M)($95.40M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($59.61M)($69.78M)($123.46M)($105.28M)($95.40M)
Net Margin %(computed)-634.33%
Per Share & EBITDA
EPS (Basic)$-50.50$-72.00$-129.00$-137.00$-138.00
Wtd Avg Shares1.18M0.97M0.96M0.78M0.69M
EBITDA($58.93M)($73.02M)($122.24M)($105.28M)($94.07M)
EBITDA Margin %(computed)-663.80%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解BioAtla, Inc.

关于BioAtla, Inc.(BCAB)损益表

BioAtla, Inc.(BCAB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BCAB实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.06B)(净利率-2980.35%)。

常见问题

BCAB · 4 问

BioAtla, Inc.(BCAB)2025财年营收为$0.00B,同比down81.8%。

BCAB revenueBCAB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09